Table 3 Univariate and multivariate analysis for pathologic complete response
Variables | ER-Positive (N = 1048) | ER-Negative (N = 797) | ||||||
|---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |||||
OR (95% CI) | P-value | OR (95% CI) | P-value | OR (95% CI) | P-value | OR (95% CI) | P-value | |
Age<35 vs. 35≤Age<50 | 1.17 (0.51–2.67) | 0.71 | 0.41 (0.05–3.19) | 0.39 | 1.92 (1.17–3.13) | 0.01 | 2.54 (1.27–5.08) | 0.01 |
PR-negative vs. –positive | 1.87 (1.01–3.47) | 0.05 | 2.00 (0.68–5.88) | 0.21 | 1.60 (0.78–3.27) | 0.20 | 5.45 (1.26–23.61) | 0.02 |
HER2-positive vs. –negative | 0.67 (0.33–1.37) | 0.28 | NI |  | 1.33 (0.82–2.16) | 0.25 | NI |  |
Proliferative index: high vs. low | 2.30 (1.02–5.20) | 0.05 | 3.45 (1.17–10.15) | 0.03 | 1.00 (0.58–1.74) | 0.99 | 1.22 (0.60–2.46) | 0.58 |
Nonpalpable vs. palpable | 3.28 (0.93–11.54) | 0.06 | 1.61 (0.20–13.16) | 0.66 | 2.27 (0.93–5.53) | 0.07 | 3.95 (1.32–11.8) | 0.01 |